Keyphrases
Esophageal Adenocarcinoma
100%
Nodal Metastasis
100%
Olfactomedin 4
100%
Lymph Node Metastasis
66%
Early Esophageal Adenocarcinoma
55%
Intestinal Stem Cell Marker
22%
Netherlands
11%
Number of Patients
11%
Immunohistochemistry
11%
Overall Survival
11%
Treatment Modalities
11%
Erasmus
11%
Rotterdam
11%
Poor Differentiation
11%
Multivariable
11%
Discriminative Value
11%
Low Expression
11%
University Medical Centre
11%
Single Treatment
11%
Surgical Resection
11%
Resection Specimen
11%
Esophageal Squamous Cell Carcinoma
11%
Disease-free Survival
11%
Informative Markers
11%
Preoperative Evaluation
11%
Esophagectomy
11%
Differentiation Grade
11%
Gastroesophageal Junction
11%
PT1b
11%
Institutional Database
11%
Medicine and Dentistry
Nodal Metastasis
100%
Esophageal Adenocarcinoma
100%
Lymph Node Metastasis
54%
Biological Marker
18%
Cell Marker
18%
Intestinal Stem Cell
18%
Immunohistochemistry
9%
Overall Survival
9%
Surgery
9%
Esophagus
9%
Adenocarcinoma
9%
Esophagectomy
9%
Disease Free Survival
9%
Gastroesophageal Junction
9%
Preoperative Evaluation
9%
Biochemistry, Genetics and Molecular Biology
Stem Cell Marker
100%
Overall Survival
50%
Esophagus
50%
Disease Free Survival
50%
Pharmacology, Toxicology and Pharmaceutical Science
Esophageal Adenocarcinoma
100%
Lymph Node Metastasis
54%
Biological Marker
18%
Cell Marker
18%
Overall Survival
9%
Disease Free Survival
9%
Adenocarcinoma
9%